Search
for
Sort by
Research 391–420 of 1000+
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- Increased blood level of urea and creatinine after chemotherapy in breast cancer patients
- The Application Progress of Tumor Microenvironment-Responsive Drug Carriers in Precision Chemotherapy
- Symptom Experience of Lung Cancer Patients Treated With Immunotherapy Combined with Chemotherapy: A Longitudinal Study
- Symptom Experience and Coping Strategies Among Patients with Breast Cancer Receiving Chemotherapy
- S-l Combined with Paclitaxel as Second-line Chemotherapy for Advanced Gastric Cancer
- ASSESSMENT OF SOCIODEMOGRAPHIC CHARACTERISTICS AND COMPARATIVE ANALYSIS OF ADVERSE DRUG REACTIONS AMONG OROPHARYNGEAL CANCER PATIENTS RECEIVING DIFFERENT CHEMOTHERAPEUTIC REGIMENS IN KARACHI, SINDH, PAKISTAN
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- The manipulation of the cedrol metabolism pathway by baricitinib and its immune interaction mechanism against chemotherapy-induced alopecia
- Role of Herbomineral Drugs in the Management of Diarrhea and Late Effects of Chemotherapy in the Patient of Oral Cavity Cancer
- SKIN TARGETING OF AN OPTIMIZED CAFFEINE NANOSTRUCTURED LIPID CARRIER WITH IMPROVED EFFICIENCY AGAINST CHEMOTHERAPY INDUCED ALOPECIA
- Skin Targeting of An Optimized Caffeine Nanostructured Lipid Carrier With Improved Efficiency Against Chemotherapy Induced Alopecia
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Surgery experiences of patients with hematologic cancer, individual applications for the symptoms due to chemotherapy and determination of the anxiety levels
- 4227 POSTER Evaluation of a Trichometer to Quantify the Prevention of Hair Loss by Scalp Cooling During Chemotherapy
- Effect of Trigonella foenum-graecum Linn. (seeds) and Butea monosperma Lam. (flowers) on chemotherapy- induced alopecia Trigonella foenum-graecum Linn. (tohum) ve Butea monosperma Lam. (çiçek)'in kemoterapi ile uyarilan alopesi üzerine etkileri
- Bioactive peptides derived from food proteins preventing lifestyle‐related diseases
- Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- The Hair Follicle as an Estrogen Target and Source
- Permanent alopecia after cranial irradiation: Dose–response relationship
- DERMAL-EPIDERMAL INTERACTIONS
- Oral retinoids-present status
- Growth factors and cytokines in hair follicle development and cycling: recent insights from animal models and the potentials for clinical therapy
- Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study